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described a potent and sequence-speciﬁc interference
with gene expression mediated by double-stranded
RNA [1]. Their landmark discovery of ‘‘RNA interfer-
ence” (RNAi) was honoured with the Nobel Prize for
Physiology or Medicine in 2006 and has spurred intense
research of this novel mechanism of gene regulation.
Within a few years, we have learned a lot about the bio-
chemistry of RNAi and related silencing mechanisms,
including the molecular steps during the process and
the composition of involved protein machineries. In par-
allel, our appreciation of the exceptional importance of
RNAi has grown rapidly as its fundamental role for the
orchestration of gene expression and the defence against
invading foreign nucleic acids is beginning to unfold.
It has emerged that short ca. 22 nt long RNA
duplexes are the key eﬀectors of RNAi and that a com-
mon core mechanism exists that is responsible for pro-
cessing double-stranded RNA into these guide
structures directing sequence-speciﬁc gene silencing
(Fig. 1A). In addition, we are now aware of a large fam-
ily of endogenous RNA molecules, consisting of over
400 diﬀerent members in humans, called micro RNAs0168-8278/$34.00  2008 European Association for the Study of the Liver.
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of gene regulation. During miRNA biogenesis initiated
by RNA polymerase II transcription of a so called
‘‘pri-miRNA”, two processing steps carried out by the
nuclear RNase III enzyme Drosha and the cytoplasmic
Dicer yield an imperfect RNA duplex carrying 2 nt
30overhangs on each strand. One of the strands is subse-
quently incorporated into an RNA-induced silencing
complex (RISC). In this context, the miRNA guides
the assembly to its cognate mRNA resulting in cleavage
of the mRNA in case of perfect or nearly perfect com-
plementarity or translational repression for imperfectly
base paired miRNAs.
While it has been observed for some time that
miRNAs play a key role in regulating gene expression
of cellular mRNAs, evidence is now mounting that they
also profoundly inﬂuence virus replication and patho-
genesis [2]. Given the intimate relation between viruses
and its host, the marked dependence of viruses on cellu-
lar factors and the key role of miRNAs in shaping the
host cell proteome, this may not be so surprising. Yet
the skill by which viruses have evolved to usurp the
miRNA system is remarkable: while various DNA
viruses like for instance human cytomegalovirus
(hCMV) encode miRNAs modulating the host cell envi-
ronment conducive for virus propagation thus taking
advantage of the host’s miRNAmachinery [3,4], the hep-
atitis C virus (HCV) was recently recognized to usurp an
endogenous miRNA highly expressed in liver cells to
promote virus replication [5,6]. HCV is an RNA virus
of the family Flaviviridae that replicates in hepatocytes
and is a major cause of chronic hepatitis, liver cirrhosisPublished by Elsevier B.V. All rights reserved.
Fig. 1. (A) Illustration of the steps and proteins involved in the process of microRNA-dependent gene regulation. (B) Schematic diagram of the HCV
genome. The target sites for miRNAs known to regulate HCV RNA replication are indicated.
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canonical outcome of miRNA-dependent gene regula-
tion where binding of the miRNA to its cognate target
sequence in the 30untranslated region of an mRNA
results in translational repression, occupation of a tan-
dem binding site within the 50non-translated region of
the HCV genome by miRNA122 results in elevated
HCV RNA levels [5,6]. Although the molecular mecha-
nism of this surprising positive regulation has not been
completely elucidated, this represents an intriguing
example where a miRNA up regulates the abundance
of a replicating viral RNA.
In a study presented in this issue of the Journal [7],
Murakami and colleagues employed an algorithm-based
search to identify endogenous miRNAs that may con-
trol HCV RNA replication. Using this approach, miR-
199a* was recognized to have partial complementary
to a conserved region within the HCV 50 untranslated
region (UTR). MiR-199a* is expressed in liver cells,albeit with much lower abundance when compared to
miR-122 [7–9]. Based on a comprehensive set of experi-
ments the authors conclusively show that this miRNA
down-regulates RNA replication of full length HCV
replicons of the Con1 (genotype 1b) and the JFH1
(genotype 2a) strain. This inhibition seems to be directly
mediated by miR-199a* since administration of anti-
sense oligonucleotides (ASOs) sequestering the miRNA
increased HCV RNA replication to an extent that was
statistically signiﬁcant. Further conﬁrming the
sequence-speciﬁcity of the miRNA-based negative regu-
lation, Murakami et al. mutated the HCV sequences
complementary to miR-199a* within the 50NTR of a
genotype 1b replicon, or alternatively used miRNAs
with 3 or 5 mismatch mutations. In both cases, respon-
siveness of HCV RNA replication was lost, indicating
that a direct sequence speciﬁc interaction between the
HCV RNA and the miRNA was responsible for the
observed modulation. As expected for miRNA-medi-
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miRNA appeared to be independent of the interferon
(IFN) pathway, since – at least at the transcriptional
level – typical IFN-induced anti-viral eﬀectors like 20–
50-oligoadenylate synthase (20–50-OAS), protein kinase
R (PKR) or MxA were not upregulated by administra-
tion of miR-199a*. Finally, when using infection assays
either with patient serum-derived HCV particles (geno-
type 1b or 2a) or cell culture-derived JFH1 viruses,
pre-treatment of target cells with miR199a* reduced
HCV copy numbers in the infected cells, while depletion
of endogenous levels of the miRNAs by ASO slightly
raised HCV RNA abundance. Together, these data con-
ﬁrm a regulatory role of miR-199a* on HCV replication
also upon infection.
The novel ﬁndings by Murakami and colleagues
extend our knowledge of interactions between patho-
gens and endogenous miRNAs and suggest that HCV
replication is limited by miR-199a*. Although not
explicitly analyzed in their study, according to the nor-
mal mode of gene regulation by miRNAs, it is reason-
able to assume that this miRNA down-regulates HCV
RNA replication by repressing translation of the HCV
polyprotein or by mediating cleavage of the viral gen-
ome. Irrespective of the precise molecular mechanism,
the aforementioned miRNA clearly operates in a diﬀer-
ent mode compared to miR-122 which is known to
increase HCV RNA abundance [5,6]. Why the interac-
tion of HCV with diﬀerent endogenous miRNAs has
discrepant outcome and how interaction with miR122
causes increased HCV RNA replication rather than
translational repression or genome degradation is pres-
ently unclear. Of note, Jopling et al. recently observed
that transfer of the miR-122 binding site to the 30UTR
of a reporter mRNA mediates translational repression
of this mRNA, indicating that miR-122 exerts dual
functions in a context dependent manner [5]. Since inser-
tion of the miR-122 site into the 50UTR of a reporter
RNA had no eﬀect on translation or mRNA stability
and due to the ﬁnding of Murakami that miR-199a*
which also targets a stretch within the 50UTR of HCV
decreases HCV replication it is unlikely that miR-122
exerts its positive eﬀect on HCV replication simply due
to the positioning of its binding site within the 50UTR
of HCV. Nevertheless, given the high degree of second-
ary RNA structures contained within the 50UTR of
HCV which are mediated by complementary basepair-
ing and play a pivotal role for HCV translation and
replication, it is possible that interaction with an
endogenous miRNA may ﬁne tune the composition or
conformation of these structures in a highly position
dependent manner thus aﬀecting replication eﬃciency.
To which extent these miRNAs modulate HCV repli-
cation or inﬂuence HCV tropism in vivo remains to be
determined. It is conceivable that expression of a set
of miRNAs with target sequences in conserved regionsof the HCV genome could signiﬁcantly limit virus repli-
cation. Alternatively, absence of a miRNA essential for
eﬃcient HCV replication may similarly restrict HCV
propagation. In agreement with the latter hypothesis,
Chang at al. recently described substantially increased
HCV replication in a human kidney-derived cell line
(293 cells) upon ectopic expression of miR-122 [10]. In
accordance with these data, limited availability of
miR-122 which is expressed in a liver-speciﬁc manner
may contribute to the restricted tropism of HCV by pre-
venting spread to tissues with low levels of miR-122. In
turn, while miR-199a* is expressed in liver cells only at
low levels [7–9], high quantities of these miRNAs in
extrahepatic tissues may preclude eﬃcient HCV replica-
tion. Therefore, depending on the host cell and the tis-
sue-speciﬁc (or species-speciﬁc) proﬁle of expressed
miRNAs, HCV may encounter more or less favourable
conditions for infection and replication. Recent data by
Randall et al. suggest that within human liver cells, the
machinery essential for processing of dsRNA into
mature miRNAs is important for eﬃcient HCV replica-
tion and infection [8]. Using Huh-7 hepatoma cells as a
model and cell culture-derived infectious HCV particles,
this group silenced expression of various host proteins
required for miRNA biogenesis which caused clearly
reduced HCV infection and replication. In combination
with the ﬁndings of Murakami et al. these data therefore
imply that in these cells the positive eﬀect of miR-122 on
HCV replication and possibly its eﬀect on additional
host genes as well as regulatory eﬀects of other miRNAs
are dominant over the miR199a*-dependent restriction.
Considering the aptitude of HCV to establish life long
persistent infection of the liver, the virus apparently
has well adapted not only to the speciﬁc set of host pro-
teins expressed in this tissue, but also to the hepatocyte-
speciﬁc miRNA environment.
The excellent potential of RNAi for therapeutic appli-
cations has been well recognized. However, when consid-
ering miRNAs as possible eﬀectors the possibly broad
speciﬁcity of these regulators of gene expression needs
to be carefully evaluated. Since recognition of target
mRNAs does not rely on perfect complementarity, a
set of mRNAs rather than a single transcript can be
aﬀected by a single miRNA usually not expressed in a
given tissue. Accordingly, Murakami et al. observed a
large number of diﬀerentially regulated host genes upon
introduction of miR-199a* into human hepatoma cells
[7]. Nevertheless, studies like the one by Murakami and
Jopling are beginning to unravel novel ‘‘Achilles heels”
in the intricate network of interactions between a viral
pathogen and its host. Considering the highly eﬃcient
endogenous RNAi machinery and hoping that the
remarkable ﬁndings about the mechanisms of RNAi will
be paralleled by rapid progress optimizing in vivo stabil-
ity, delivery and speciﬁcity, therapeutic application may
become within reach in the near future.
444 T. Pietschmann / Journal of Hepatology 50 (2009) 441–444Acknowledgement
Work in the author’s laboratory is supported by an
Emmy Noether fellowship of the Deutsche Forschungs-
gemeinschaft (PI 734/1-1), by grants from the Helmholtz
Association SO-024, by the Initiative and Networking
Fund of the Helmholtz Association within the Helm-
holtz Alliance on Immunotherapy of Cancer, by the
International Research Training Group IRTG1273,
and by the Indo-German Science Center. The author
is grateful to Sandra Ciesek and Eike Steinmann for crit-
ical reading of the manuscript.References
[1] Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello
CC. Potent and speciﬁc genetic interference by double-stranded
RNA in Caenorhabditis elegans. Nature 1998;391:806–811.
[2] Gottwein E, Cullen BR. Viral and cellular microRNAs as
determinants of viral pathogenesis and immunity. Cell Host
Microbe 2008;3:375–387.[3] Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh
N, Biton M, et al. Host immune system gene targeting by a viral
miRNA. Science 2007;317:376–381.
[4] Reeves MB, Davies AA, McSharry BP, Wilkinson GW, Sinclair
JH. Complex I binding by a virally encoded RNA regulates
mitochondria-induced cell death. Science 2007;316:1345–1348.
[5] Jopling CL, Schutz S, Sarnow P. Position-dependent function for
a tandem microRNA miR-122-binding site located in the hepatitis
C virus RNA genome. Cell Host Microbe 2008;4:77–85.
[6] Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P.
Modulation of hepatitis C virus RNA abundance by a liver-
speciﬁc MicroRNA. Science 2005;309:1577–1581.
[7] Murakami Y, Aly HH, Tajima A, Inoue I, Shimotohno K.
Regulation of the hepatitis C virus genome replication by miR-
199a. J Hepatol 2009;50:453–460.
[8] Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets
KE, Pfeﬀer S, et al. Cellular cofactors aﬀecting hepatitis C virus
infection and replication. Proc Natl Acad Sci USA 2007;104:
12884–12889.
[9] Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W,
Tuschl T. Identiﬁcation of tissue-speciﬁc microRNAs from
mouse. Curr Biol 2002;12:735–739.
[10] Chang J, Guo JT, Jiang D, Guo H, Taylor JM, Block TM. Liver
speciﬁc microRNA, miR-122, enhances the replication of hepatitis
C virus in non-hepatic cells. J Virol 2008;82:8215–8223.
